Serum β-hCG as an Indicator of Recurrence After the Complete Resection of a Malignant Solitary Fibrous Tumor of the Pleura

详细信息    查看全文

• 作者：Hiroshi Yabuki ; MD^a ; Akira Sakurada ; MD ; PhD^a ; ^{akira.sakurada.c5@tohoku.ac.jp" class="auth_mail" title="E-mail the corresponding author} ; Hiromichi Niikawa ; MD ; PhD^a ; Hirotsugu Notsuda ; MD ; PhD^a ; Chiaki Endo ; MD ; PhD^a ; Yasushi Matsuda ; MD ; PhD^a ; Masafumi Noda ; MD ; PhD^a ; Ryoko Saito ; MD ; PhD^b ; Shinichi Yamashita ; MD ; PhD^c ; Yoichi Arai ; MD ; PhD^c ; Yoshinori Okada ; MD ; PhD^a
• 刊名：The Annals of Thoracic Surgery
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：102
• 期：6
• 页码：e551-e553
• 全文大小：1047 K

文摘

In solitary fibrous tumors (SFTs) of the pleura, malignant SFTs are uncommon. Although SFTs are known to cause paraneoplastic syndromes through the production of insulin-like growth factor, to the best of our knowledge, the production of beta-human chorionic gonadotropin (β-hCG) has been reported only in 1 case involving a patient with a benign SFT. We herein report the first case of the elevation of β-hCG serum levels associated with a malignant SFT in which the β-hCG serum level became a useful indicator of recurrence after the complete resection of the primary mediastinal lesion.